| ACE | Angiotensin converting enzyme |
| APACC | Association pour la Prevention par l’Aspirine du Cancer Colorectal |
| APC | Adenomatous polyposis coli |
| ASA | Aspirin |
| BCL-2 | B-cell lymphoma 2 |
| CAPP2 | The Colorectal/Adenoma/Carcinoma Prevention Programme 2 |
| CAPS | Colorectal Adenoma Prevention Study |
| CHIP | Clonal hematopoiesis of indeterminate potential; Children’s International Polyposis |
| COX | Cyclooxygenase |
| CRC | Colorectal cancer |
| DFMO | Difluoromethylornitine |
| DNA | Deoxyribonucleic acid |
| FAP | Familial adenocarcinoma polyposis |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| HNPCC | Hereditary non-polyposis colorectal cancer |
| IL-1β | Leukocytic pyrogen |
| IL-6 | Interleukin 6 |
| IL-23 | Interleukin 23 |
| ITT | Intention-to-treat analysis |
| IκB | Inhibitor of nuclear factor kappa B |
| NF-κB | Nuclear factor-kappa B |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| PGHS | Prostaglandin endoperoxide synthase |
| PPARs | Peroxisome proliferator-activated receptors |
| PreSAP | Prevention of Colorectal Sporadic Adenomatous Polyps |
| STAT3 | Signal transducer and activator of transcription 3 |
| RNA | Ribonucleic acid |
| TDP | Time to disease progression |
| TNF-α | Tumor necrosis factor-alpha |
| WHS | Women’s Health Study |
| 15-LOX-1 | 15-Lipooxygenase 1 |